Celgosivir

AGAR BILE ESCULIN 500G 1/EA

Immunogen cementum protein 1 Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

Immunogen centromere protein V recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by

Immunogen centromere protein V recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by

Caldaret.

Cendakimab (anti-IL-13) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab (anti-IL-13) has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both

Cendakimab (anti-IL-13) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab (anti-IL-13) has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both

Cendakimab (anti-IL-13) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab (anti-IL-13) has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both

Cendakimab (anti-IL-13) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab (anti-IL-13) has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both

G CVRGLAS NO 1 50X24MM 1 OZ/PK

G CVRGLAS NO 1 50X24MM 1 OZ/PK

A cell-permeable, 3-hydroxychromone derived compound that acts as a selective and reversible inhibitor of GSK-3&#946 (IC 50 &lt100 nM). Shown to increase phosphorylation at Ser9.